John Dessauer's Investors World Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : John Dessauer's Investors World

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Diogeron who wrote (1990)	1/23/1999 10:19:00 AM
From: robert emann	Read Replies (1) of 2346

Dear Diogeron; I have not seen the WSJ article yet but will try to see it at my nearby library. I bought some about 12-18 months ago in the mid $50 range with the intent of holding for a long time. Ever since then I noticed every analyst criticizes Novartis for slow single digit top line sales growth yet earnings continue to improve nicely and the market price is up about 80% plus there was a distribution not to long ago for the chemical business. Not a bad return. Not a trading stock , but good buy and hold type. Regards Bob

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next